BioLargo IncOTCQX US:BLGO
- LAST PRICE0.2120
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.2130/ 25
- Ask / Lots0.2160/ 25
- Open / Previous Close--- / 0.2120
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Oct 28, 2024
BioLargo, Inc. to Present at the LD Micro Main Event XVII, from 8:32AM ET on Monday Oct 28, 2024 by Dow Jones
8:32AM ET on Monday Oct 28, 2024 by Dow Jones
Oct 14, 2024
BioLargo Validates Key Performance Metrics of Its Cellinity Battery Energy Storage Technology, from 8:45AM ET on Monday Oct 14, 2024 by Dow Jones
8:45AM ET on Monday Oct 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BioLargo Inc | 63.7M | -22.2x | --- |
Sustainable Projects Group Inc | 59.2M | -19.3x | --- |
Syntec Optics Holdings Inc | 49.9M | 75.8x | --- |
Lithium & Boron Technology Inc | 18.6K | 0.0x | --- |
Nano Magic Inc | 10.8M | -3.1x | --- |
Advanced Container Technologies Inc | 5.2K | 0.0x | --- |
Company Information
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company operates through six segments: ONM Environmental, Clyra Medical Technologies (Clyra Medical), BioLargo Engineering (BLEST), BioLargo Canada, Inc. (Canada), BioLargo Energy Technologies, Inc. (BETI), and BioLargo Equipment Solutions & Technologies, Inc. (BEST). ONM Environmental segment engaged in selling odor and volatile organic control products and services. Clyra Medical segment develops and sells medical products based on its technologies. BLEST segment provides professional engineering services on a time and materials basis for outside clients and supports its internal operations as needed. Its Canada segment is the main hub of its scientists researching and developing its technologies. Its BETI segment is engaged in developing its proprietary battery technology. BEST segment manages the sales and distribution of its water treatment products and related services.
Contact Information
- Headquarters
- 14921 Chestnut St.WESTMINSTER, CA, United States 92683
- Phone
- 949-643-9540
- Fax
- 949-625-9819
Executives
- Chairman of the Board, President, Chief Executive Officer
- Dennis Calvert
- Chief Financial Officer
- Charles Dargan
- Executive Vice President - Operations, Corporate Secretary, Director
- Joseph Provenzano
- Chief Scientific Officer, Director
- Kenneth Code
- Director
- Larry Dick
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $63.7M |
|---|---|
Revenue (TTM) | $16.8M |
Shares Outstanding | 300.6M |
BioLargo Inc does not pay a dividend. | |
Beta | 0.22 |
EPS | $-0.01 |
Book Value | $0.02 |
P/E Ratio | -22.2x |
Price/Sales (TTM) | 3.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -24.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
